ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 277 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q3 2022. The put-call ratio across all filers is 0.78 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,490,064 | -16.9% | 129,887 | +10.2% | 0.00% | 0.0% |
| Q2 2023 | $4,201,925 | +35.6% | 117,833 | -3.4% | 0.00% | 0.0% |
| Q1 2023 | $3,099,613 | -38.1% | 122,032 | -1.2% | 0.00% | -33.3% |
| Q4 2022 | $5,008,470 | +22.3% | 123,483 | -0.3% | 0.00% | 0.0% |
| Q3 2022 | $4,094,102 | -8.7% | 123,876 | -2.7% | 0.00% | 0.0% |
| Q2 2022 | $4,484,416 | -24.1% | 127,362 | -0.9% | 0.00% | -25.0% |
| Q1 2022 | $5,908,841 | -46.6% | 128,481 | -23.1% | 0.00% | -42.9% |
| Q4 2021 | $11,070,000 | +4.4% | 166,967 | -1.7% | 0.01% | -22.2% |
| Q3 2021 | $10,607,000 | -24.1% | 169,908 | +0.7% | 0.01% | -18.2% |
| Q2 2021 | $13,975,000 | +22.8% | 168,740 | -1.7% | 0.01% | +10.0% |
| Q1 2021 | $11,384,000 | -18.2% | 171,673 | -5.3% | 0.01% | -23.1% |
| Q4 2020 | $13,916,000 | +70.3% | 181,369 | -4.4% | 0.01% | +62.5% |
| Q3 2020 | $8,170,000 | -1.1% | 189,743 | -2.1% | 0.01% | 0.0% |
| Q2 2020 | $8,260,000 | +41.1% | 193,891 | -4.7% | 0.01% | +33.3% |
| Q1 2020 | $5,855,000 | -52.4% | 203,513 | +5.0% | 0.01% | -53.8% |
| Q4 2019 | $12,291,000 | +689.4% | 193,774 | +235.6% | 0.01% | +550.0% |
| Q3 2019 | $1,557,000 | +1.8% | 57,744 | +0.1% | 0.00% | 0.0% |
| Q2 2019 | $1,529,000 | +37.0% | 57,701 | -5.1% | 0.00% | +100.0% |
| Q1 2019 | $1,116,000 | +70.1% | 60,791 | +15.1% | 0.00% | 0.0% |
| Q4 2018 | $656,000 | -39.3% | 52,802 | -6.3% | 0.00% | 0.0% |
| Q3 2018 | $1,080,000 | +22.6% | 56,340 | -13.0% | 0.00% | 0.0% |
| Q2 2018 | $881,000 | +5082.4% | 64,788 | +2619.9% | 0.00% | – |
| Q1 2018 | $17,000 | +70.0% | 2,382 | -12.4% | 0.00% | – |
| Q4 2017 | $10,000 | +233.3% | 2,718 | +329.4% | 0.00% | – |
| Q3 2017 | $3,000 | 0.0% | 633 | -67.4% | 0.00% | – |
| Q2 2017 | $3,000 | -95.8% | 1,944 | -94.9% | 0.00% | – |
| Q1 2017 | $71,000 | +255.0% | 38,148 | +198.4% | 0.00% | – |
| Q4 2016 | $20,000 | -93.7% | 12,785 | -70.4% | 0.00% | – |
| Q3 2016 | $317,000 | +37.8% | 43,194 | +0.1% | 0.00% | – |
| Q2 2016 | $230,000 | – | 43,145 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 908,474 | $24,410,696 | 22.12% |
| Western Financial Corp/CA | 820,239 | $22,039,822 | 16.16% |
| JOHNSON & JOHNSON | 247,598 | $6,652,958 | 2.45% |
| WEALTH EFFECTS LLC | 164,750 | $4,426,835 | 2.19% |
| M28 Capital Management LP | 67,400 | $1,811,038 | 2.08% |
| Privium Fund Management B.V. | 259,036 | $6,960,298 | 2.07% |
| Evolutionary Tree Capital Management, LLC | 51,266 | $1,377,517 | 1.78% |
| Avidity Partners Management LP | 1,063,897 | $28,586,912 | 1.15% |
| SECTORAL ASSET MANAGEMENT INC | 157,552 | $4,233,422 | 0.82% |
| Vivo Capital, LLC | 137,411 | $3,692,234 | 0.40% |